43
Participants
Start Date
June 30, 2010
Primary Completion Date
June 30, 2011
Study Completion Date
August 31, 2011
Cystagon® (Cysteamine Bitartrate)
"Run-in Period (Weeks 1, 2, 3) and Period 1 (Weeks 4, 5, 6) or Period 2 (Weeks 7, 8, 9); Immediate crossover to opposite treatment than taken during Period 1:~Every 6H, supplied in 150 and 50mg capsules/Duration of Treatment: 3 weeks each period used"
Cysteamine Bitartrate Delayed-release Capsules (RP103)
"Period 1 (Weeks 4, 5, 6) or Period 2 (Weeks 7, 8, 9); Immediate crossover to opposite treatment than taken during Period 1:~Every 12H, supplied in 75 and 25mg capsules/Duration of Treatment: 3 weeks"
Emory Children's Center, Atlanta
Ann & Robert H. Lurie Children's Hospital of Chicago (formerly Children's Memorial Hospital), Chicago
Stanford University Medical School, Stanford
Hospices Civils de Lyon, Lyon
Villeneuve-Lapeyronie Hospital, Montpellier
Necker Hospital, Paris
Robert Debre Hospital, Paris
Radboud University Nijmegen Medical Center, Nijmegen
Lead Sponsor
Amgen
INDUSTRY